AXL (P30530) variants and mutations
AXL (also known as P30530) is a human protein-coding gene encoding a tyrosine-protein kinase receptor UFO protein. Activation by GAS6 promotes cell survival, migration, immune modulation, and resistance to cellular stress. Persistent signaling is common in advanced cancers and can support epithelial-to-mesenchymal transition, metastasis, and resistance to targeted or immune therapies. This analysis covers 1,797 AXL variants and mutations. Of these, 56% have computational variant effect predictions. Disease context includes acute myeloid leukemia, neurodegenerative disease, and Alzheimer disease. Example AXL variants include M1R, A2E, and A2V.
Variant analysis overview
- Gene: AXL
- Protein: P30530
- UniProt accession: P30530
- Organism: Homo sapiens
- Variants analyzed: 1797
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 1,614 unspecified-consequence records; 92 missense variants; 69 synonymous variants; 10 stop-gained variants; 6 frameshift variants; 4 splice-region variants; 2 in-frame deletions; 1 substitution
- Prediction scores: 1,004 variants have prediction scores (56% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: acute myeloid leukemia, neurodegenerative disease, Alzheimer disease, multiple sclerosis, Parkinson disease, lysosomal storage disease, dengue disease, neoplasm, myeloid leukemia, acute myeloid leukemia by FAB classification, head and neck squamous cell carcinoma, myelodysplastic syndrome.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 5 domains; 2 binding sites; 11 post-translational modification sites.
- Structural context: 1,414 variants have structural context.
- PTM context: 21 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable AXL variants
Examples include M1R, A2E, A2V, A2S, A2T, A2A, W3*, W3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1R (p.Met1Arg), rs2033742689, ClinGen CA405980059, ClinVar RCV003684627, Uncertain significance, not specified
- A2E (p.Ala2Glu), 1000Genomes rs10411373, ExAC rs10411373, TOPMed rs10411373, gnomAD rs10411373, REVEL 0.06, CADD 4.25, Uncertain significance
- A2V (p.Ala2Val), rs10411373, ClinGen CA9457810, ClinVar RCV003554155, 1000Genomes rs10411373, REVEL 0.07, CADD 6.43, Uncertain significance, not provided
- A2S (p.Ala2Ser), gnomAD 19-41219396-G-T, REVEL 0.10, CADD 11.50
- A2T (p.Ala2Thr), gnomAD 19-41219396-G-A, REVEL 0.10, CADD 13.30
- A2A (p.Ala2Ala), gnomAD 19-41219398-G-T, CADD 7.04
- W3* (p.Trp3Ter), gnomAD 19-41219400-G-A, CADD 32.00
- W3L (p.Trp3Leu), gnomAD 19-41219400-G-T, REVEL 0.22, CADD 10.20
- W3S (p.Trp3Ser), gnomAD 19-41219400-G-C, REVEL 0.20, CADD 10.70
- W3C (p.Trp3Cys), gnomAD 19-41219401-G-T, REVEL 0.16, CADD 18.30
- R4G (p.Arg4Gly), 1000Genomes rs182481095, ExAC rs182481095, TOPMed rs182481095, gnomAD rs182481095, REVEL 0.10, CADD 15.10
- R4Q (p.Arg4Gln), rs779811231, ClinGen CA9457815, cosmic curated COSV56567, ClinVar RCV004222734, REVEL 0.08, CADD 16.90, Uncertain significance, not specified
- R4W (p.Arg4Trp), cosmic curated COSV10737, 1000Genomes rs182481095, ExAC rs182481095, TOPMed rs182481095, REVEL 0.16, CADD 14.60
- R4R (p.Arg4Arg), rs182481095, gnomAD 19-41219402-C-A, CADD 4.46
- R4L (p.Arg4Leu), gnomAD 19-41219403-G-T, REVEL 0.09, CADD 16.60
- C5G (p.Cys5Gly), Ensembl rs2122191479
- C5Y (p.Cys5Tyr), ExAC rs746493416, gnomAD rs746493416, REVEL 0.12, CADD 18.50
- C5R (p.Cys5Arg), gnomAD 19-41219405-T-C, REVEL 0.16, CADD 22.40
- C5F (p.Cys5Phe), gnomAD 19-41219406-G-T, REVEL 0.10, CADD 17.30
- C5W (p.Cys5Trp), gnomAD 19-41219407-C-G, REVEL 0.20, CADD 17.10
- C5C (p.Cys5Cys), rs1599722294, gnomAD 19-41219407-C-T, CADD 9.88
- P6H (p.Pro6His), TOPMed rs997221035, gnomAD rs997221035, REVEL 0.07, CADD 1.62
- P6L (p.Pro6Leu), TOPMed rs997221035, gnomAD rs997221035, REVEL 0.12, CADD 1.80
- P6S (p.Pro6Ser), gnomAD 19-41219408-C-T, REVEL 0.04, CADD 7.98
- P6P (p.Pro6Pro), gnomAD 19-41219410-C-A, CADD 10.70
- R7G (p.Arg7Gly), Ensembl rs2033743334, REVEL 0.21, CADD 24.10
- R7T (p.Arg7Thr), ExAC rs776668582, gnomAD rs776668582, REVEL 0.16, CADD 23.30
- R7W (p.Arg7Trp), gnomAD 19-41219411-A-T, REVEL 0.30, CADD 28.60
- R7M (p.Arg7Met), gnomAD 19-41219412-G-T, REVEL 0.26, CADD 25.70
- R7R (p.Arg7Arg), rs761863392, gnomAD 19-41219413-G-A, CADD 12.50
- R7S (p.Arg7Ser), gnomAD 19-41219413-G-T, REVEL 0.33, CADD 23.80
- M8K (p.Met8Lys), gnomAD rs1297688569, REVEL 0.39, CADD 25.00
- M8V (p.Met8Val), Ensembl rs2122191562
- G9D (p.Gly9Asp), Ensembl rs2122191580, REVEL 0.23, CADD 13.30
- G9S (p.Gly9Ser), TOPMed rs1256818203, gnomAD rs1256818203, REVEL 0.26, CADD 25.00
- G9C (p.Gly9Cys), gnomAD 19-41219417-G-T, REVEL 0.39, CADD 26.20
- G9R (p.Gly9Arg), gnomAD 19-41219417-G-C, REVEL 0.39, CADD 25.60
- G9V (p.Gly9Val), gnomAD 19-41219418-G-T, REVEL 0.37, CADD 21.80
- G9G (p.Gly9Gly), gnomAD 19-41219419-C-T, CADD 13.30
- R10S (p.Arg10Ser), ExAC rs769574605, REVEL 0.24, CADD 24.80
- R10T (p.Arg10Thr), gnomAD 19-41219421-G-C, REVEL 0.30, CADD 23.70
- R10M (p.Arg10Met), gnomAD 19-41219421-G-T, REVEL 0.32, CADD 24.10
- V11F (p.Val11Phe), gnomAD 19-41219423-G-T, REVEL 0.19, CADD 18.60
- V11V (p.Val11Val), gnomAD 19-41219425-C-G, CADD 6.19
- P12L (p.Pro12Leu), 1000Genomes rs563334837, ExAC rs563334837, TOPMed rs563334837, gnomAD rs563334837, REVEL 0.09, CADD 5.88, Uncertain significance, not specified
- P12Q (p.Pro12Gln), cosmic curated COSV99996, 1000Genomes rs563334837, ExAC rs563334837, TOPMed rs563334837, REVEL 0.21, CADD 12.30
- P12S (p.Pro12Ser), gnomAD 19-41219426-C-T, REVEL 0.05, CADD 7.42
- P12T (p.Pro12Thr), gnomAD 19-41219426-C-A, REVEL 0.05, CADD 8.20
- P12P (p.Pro12Pro), rs530407469, gnomAD 19-41219428-G-A, CADD 4.04
- L13P (p.Leu13Pro), TOPMed rs2033743893, REVEL 0.48, CADD 23.00
- L13L (p.Leu13Leu), gnomAD 19-41219431-G-A, CADD 10.60
- A14T (p.Ala14Thr), Ensembl rs112524750, REVEL 0.23, CADD 24.50
- A14S (p.Ala14Ser), gnomAD 19-41219432-G-T, REVEL 0.22, CADD 20.90
- A14V (p.Ala14Val), gnomAD 19-41219433-C-T, REVEL 0.20, CADD 21.10
- A14A (p.Ala14Ala), rs555587960, gnomAD 19-41219434-C-T, CADD 12.90
- W15R (p.Trp15Arg), gnomAD 19-41219435-T-C, REVEL 0.48, CADD 24.20
- W15C (p.Trp15Cys), gnomAD 19-41219437-G-T, REVEL 0.55, CADD 24.00
- W15* (p.Trp15Ter), gnomAD 19-41219437-G-A, CADD 37.00
- C16Y (p.Cys16Tyr), Ensembl rs2122191647
- C16F (p.Cys16Phe), gnomAD 19-41219439-G-T, REVEL 0.29, CADD 24.00
- C16* (p.Cys16Ter), gnomAD 19-41219440-C-A, CADD 36.00
- L17M (p.Leu17Met), gnomAD rs371082541
- L17V (p.Leu17Val), gnomAD rs371082541
- L17S (p.Leu17Ser), gnomAD 19-41219442-T-C, REVEL 0.29, CADD 24.20
- A18V (p.Ala18Val), rs145867512, ClinGen CA9457825, ClinVar RCV000893940, 1000Genomes rs145867512, REVEL 0.04, CADD 0.50, Likely benign, not provided
- A18T (p.Ala18Thr), gnomAD 19-41219444-G-A, REVEL 0.19, CADD 23.60
- A18S (p.Ala18Ser), gnomAD 19-41219444-G-T, REVEL 0.19, CADD 23.60
- A18A (p.Ala18Ala), gnomAD 19-41219446-G-C, CADD 9.49
- L19M (p.Leu19Met), gnomAD 19-41219447-C-A, REVEL 0.28, CADD 23.80
- L19P (p.Leu19Pro), gnomAD 19-41219448-T-C, REVEL 0.45, CADD 26.00
- L19L (p.Leu19Leu), gnomAD 19-41219449-G-A, CADD 9.41
- C20R (p.Cys20Arg), ExAC rs753148751, TOPMed rs753148751, gnomAD rs753148751, REVEL 0.30, CADD 24.40
- C20F (p.Cys20Phe), gnomAD 19-41219451-G-T, REVEL 0.22, CADD 22.90
- C20C (p.Cys20Cys), rs563994782, gnomAD 19-41219452-C-T, CADD 7.13
- C20* (p.Cys20Ter), gnomAD 19-41219452-C-A, CADD 32.00
- G21D (p.Gly21Asp), gnomAD rs1423781941, REVEL 0.13, CADD 11.30
- G21S (p.Gly21Ser), ExAC rs778406577, gnomAD rs778406577, REVEL 0.09, CADD 15.40
- G21V (p.Gly21Val), gnomAD 19-41219454-G-T, REVEL 0.08, CADD 8.90
- W22* (p.Trp22Ter), gnomAD rs1166026721
- W22G (p.Trp22Gly), Ensembl rs2122191722
- W22L (p.Trp22Leu), gnomAD 19-41219457-G-T, REVEL 0.24, CADD 21.00
- A23G (p.Ala23Gly), ExAC rs754135882, TOPMed rs754135882, gnomAD rs754135882, REVEL 0.11, CADD 4.30
- A23T (p.Ala23Thr), Ensembl rs2122191736
- A23V (p.Ala23Val), cosmic curated COSV99997, ExAC rs754135882, TOPMed rs754135882, gnomAD rs754135882, REVEL 0.11, CADD 8.05
- A23A (p.Ala23Ala), rs532768963, gnomAD 19-41219461-G-T, CADD 3.85
- C24G (p.Cys24Gly), NCI-TCGA Cosmic COSV5656, cosmic curated COSV56564, Variant assessed as somatic; moderate impact.
- C24S (p.Cys24Ser), gnomAD rs909154631, REVEL 0.05, CADD 9.10
- C24W (p.Cys24Trp), TOPMed rs1389617751, gnomAD rs1389617751, REVEL 0.27, CADD 16.50
- C24Y (p.Cys24Tyr), gnomAD rs909154631, REVEL 0.05, CADD 7.31
- C24F (p.Cys24Phe), gnomAD 19-41219463-G-T, REVEL 0.10, CADD 8.46
- C24C (p.Cys24Cys), rs1389617751, gnomAD 19-41219464-C-T, CADD 6.03
- C24* (p.Cys24Ter), gnomAD 19-41219464-C-A, CADD 33.00
- M25I (p.Met25Ile), gnomAD rs1301191228, cosmic curated COSV56567, REVEL 0.07, CADD 13.30
- M25V (p.Met25Val), gnomAD rs1433040441, REVEL 0.04, CADD 0.05
- M25R (p.Met25Arg), gnomAD 19-41219466-T-G, REVEL 0.17, CADD 9.77
- M25T (p.Met25Thr), gnomAD 19-41219466-T-C, REVEL 0.06, CADD 5.71
- A26T (p.Ala26Thr), TOPMed rs1043985274, gnomAD rs1043985274, REVEL 0.07, CADD 17.70
- A26V (p.Ala26Val), ExAC rs746689495, TOPMed rs746689495, gnomAD rs746689495, REVEL 0.12, CADD 15.80
- A26S (p.Ala26Ser), gnomAD 19-41219468-G-T, REVEL 0.09, CADD 21.60
- A26D (p.Ala26Asp), gnomAD 19-41219469-C-A, REVEL 0.30, CADD 22.90
- A26A (p.Ala26Ala), gnomAD 19-41219470-C-T, CADD 8.46
- P27H (p.Pro27His), NCI-TCGA TCGA novel, TOPMed rs1000076660, gnomAD rs1000076660, REVEL 0.08, CADD 14.90, Uncertain significance
- P27L (p.Pro27Leu), rs1000076660, ClinGen CA308516381, ClinVar RCV004326366, TOPMed rs1000076660, REVEL 0.10, CADD 15.00, Uncertain significance, not specified
- P27S (p.Pro27Ser), ExAC rs768231361, TOPMed rs768231361, gnomAD rs768231361, REVEL 0.20, CADD 17.70, Uncertain significance, not specified
- P27P (p.Pro27Pro), gnomAD 19-41219473-C-A, CADD 9.30
- R28G (p.Arg28Gly), Ensembl rs2122191860
- R28S (p.Arg28Ser), cosmic curated COSV99997, TOPMed rs1336744611, gnomAD rs1336744611, REVEL 0.09, CADD 19.90
- R28Q (p.Arg28Gln), gnomAD 19-41219468-G-GC, CADD 23.50
- R28M (p.Arg28Met), gnomAD 19-41219475-G-T, REVEL 0.12, CADD 14.80
- R28R (p.Arg28Arg), rs1336744611, gnomAD 19-41219476-G-A, CADD 16.70
- G29S (p.Gly29Ser), TOPMed rs1265086297
- G29C (p.Gly29Cys), gnomAD 19-41219477-G-T, REVEL 0.29, CADD 34.00
- G29G (p.Gly29Gly), gnomAD 19-41220637-C-A, CADD 1.09
- T30K (p.Thr30Lys), TOPMed rs891614619, gnomAD rs891614619, REVEL 0.08, CADD 15.20
- T30M (p.Thr30Met), cosmic curated COSV56576, TOPMed rs891614619, gnomAD rs891614619, REVEL 0.11, CADD 18.80
- T30T (p.Thr30Thr), rs201764420, gnomAD 19-41220640-G-T, CADD 1.97
- Q31* (p.Gln31Ter), ExAC rs754682210, gnomAD rs754682210
- Q31E (p.Gln31Glu), ExAC rs754682210, gnomAD rs754682210, REVEL 0.06, CADD 7.44
- Q31K (p.Gln31Lys), ExAC rs754682210, gnomAD rs754682210, REVEL 0.07, CADD 7.45
- Q31R (p.Gln31Arg), Ensembl rs2122195252
- Q31L (p.Gln31Leu), gnomAD 19-41220642-A-T, REVEL 0.14, CADD 12.00
- A32T (p.Ala32Thr), NCI-TCGA Cosmic COSV9999, cosmic curated COSV99996, REVEL 0.07, CADD 13.20, Variant assessed as somatic; moderate impact.
- A32D (p.Ala32Asp), gnomAD 19-41220645-C-A, REVEL 0.10, CADD 16.10
- E33K (p.Glu33Lys), gnomAD 19-41220647-G-A, REVEL 0.20, CADD 16.10
- E34* (p.Glu34Ter), gnomAD 19-41220650-G-T, CADD 34.00
- E34A (p.Glu34Ala), gnomAD 19-41220651-A-C, REVEL 0.07, CADD 0.08
- S35I (p.Ser35Ile), 1000Genomes rs201081309
- S35R (p.Ser35Arg), Ensembl rs2122195267
- P36L (p.Pro36Leu), rs536724919, NCI-TCGA Cosmic COSV5656, cosmic curated COSV56567, TOPMed rs536724919, REVEL 0.23, CADD 23.30, Variant assessed as somatic; moderate impact.
- P36P (p.Pro36Pro), gnomAD 19-41220658-C-G, CADD 1.22
- F37L (p.Phe37Leu), gnomAD 19-41220659-T-C, REVEL 0.22, CADD 25.20
- F37S (p.Phe37Ser), gnomAD 19-41220660-T-C, REVEL 0.28, CADD 25.10
- F37F (p.Phe37Phe), rs1175570418, gnomAD 19-41220661-C-T, CADD 2.75
- V38G (p.Val38Gly), ExAC rs747638130, gnomAD rs747638130, REVEL 0.28, CADD 21.80
- V38L (p.Val38Leu), ExAC rs781049505, TOPMed rs781049505, gnomAD rs781049505, Uncertain significance
- V38M (p.Val38Met), rs781049505, ClinGen CA9457853, ClinVar RCV004141127, ExAC rs781049505, REVEL 0.10, CADD 19.30, Uncertain significance, not specified
- V38V (p.Val38Val), rs755688015, gnomAD 19-41220664-G-A, CADD 8.97
- G39D (p.Gly39Asp), gnomAD rs1354956512, REVEL 0.03, CADD 12.60
- N40K (p.Asn40Lys), ExAC rs777529927, gnomAD rs777529927, REVEL 0.04, CADD 15.00
- N40D (p.Asn40Asp), gnomAD 19-41220668-A-G, REVEL 0.07, CADD 17.60
- N40S (p.Asn40Ser), gnomAD 19-41220669-A-G, REVEL 0.07, CADD 13.10
- P41R (p.Pro41Arg), ExAC rs749268016, gnomAD rs749268016, REVEL 0.35, CADD 23.40
- P41T (p.Pro41Thr), gnomAD rs2033773715, REVEL 0.39, CADD 22.70
- G42A (p.Gly42Ala), Ensembl rs2122195332
- G42E (p.Gly42Glu), cosmic curated COSV56563, Ensembl rs2122195332
- G42R (p.Gly42Arg), Ensembl rs2122195321, REVEL 0.08, CADD 22.50
- N43D (p.Asn43Asp), gnomAD rs1366442221, REVEL 0.21, CADD 25.40
- N43T (p.Asn43Thr), NCI-TCGA Cosmic COSV5656, cosmic curated COSV56567, Variant assessed as somatic; moderate impact.
- I44V (p.Ile44Val), rs770570685, ClinGen CA9457858, ClinVar RCV004143770, ExAC rs770570685, REVEL 0.05, CADD 11.10, Uncertain significance, not specified
- I44N (p.Ile44Asn), gnomAD 19-41220681-T-A, REVEL 0.41, CADD 27.10
- I44I (p.Ile44Ile), rs1305030495, gnomAD 19-41220682-C-T, CADD 14.40
- T45P (p.Thr45Pro), gnomAD 19-41220683-A-C, REVEL 0.54, CADD 26.80
- T45S (p.Thr45Ser), gnomAD 19-41220683-A-T, REVEL 0.30, CADD 25.30
- T45K (p.Thr45Lys), gnomAD 19-41220684-C-A, REVEL 0.45, CADD 23.90
- G46A (p.Gly46Ala), cosmic curated COSV56565, gnomAD rs1339361889, REVEL 0.15, CADD 22.50
- G46C (p.Gly46Cys), gnomAD 19-41220686-G-T, REVEL 0.31, CADD 23.20
- G46R (p.Gly46Arg), gnomAD 19-41220686-G-C, REVEL 0.19, CADD 22.30
- A47S (p.Ala47Ser), gnomAD rs2033774057, REVEL 0.10, CADD 15.30
- A47V (p.Ala47Val), rs1260076571, gnomAD rs1260076571, REVEL 0.21, CADD 23.90, Variant assessed as somatic; moderate impact.
- A47A (p.Ala47Ala), rs1480838790, gnomAD 19-41220691-C-T, CADD 14.60
- R48P (p.Arg48Pro), rs200598880, ClinGen CA405981245, ClinVar RCV004108308, 1000Genomes rs200598880, REVEL 0.39, CADD 24.70, Uncertain significance, not specified
- R48Q (p.Arg48Gln), 1000Genomes rs200598880, ExAC rs200598880, TOPMed rs200598880, gnomAD rs200598880, REVEL 0.20, CADD 24.20, Uncertain significance
- R48W (p.Arg48Trp), rs774132867, ClinGen CA9457860, NCI-TCGA Cosmic COSV5656, cosmic curated COSV56563, REVEL 0.42, CADD 24.00, Uncertain significance, not specified
- R48R (p.Arg48Arg), rs774132867, gnomAD 19-41220692-C-A, CADD 10.50
- G49* (p.Gly49Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G49E (p.Gly49Glu), ExAC rs775741490, gnomAD rs775741490, REVEL 0.42, CADD 23.40
- G49R (p.Gly49Arg), TOPMed rs1219778701, gnomAD rs1219778701, REVEL 0.48, CADD 26.70
- G49V (p.Gly49Val), gnomAD 19-41220696-G-T, REVEL 0.74, CADD 25.70
- L50F (p.Leu50Phe), rs369684238, ClinGen CA9457863, cosmic curated COSV56575, ClinVar RCV002113945, REVEL 0.03, CADD 17.70, Likely benign, not provided
- L50I (p.Leu50Ile), ESP rs369684238, ExAC rs369684238, TOPMed rs369684238, gnomAD rs369684238, REVEL 0.03, CADD 16.20, Likely benign
- L50V (p.Leu50Val), gnomAD 19-41220698-C-G, REVEL 0.02, CADD 15.60
- T51M (p.Thr51Met), 1000Genomes rs568179015, ExAC rs568179015, TOPMed rs568179015, gnomAD rs568179015, REVEL 0.05, CADD 5.02
- T51T (p.Thr51Thr), rs55767963, gnomAD 19-41220703-G-A, CADD 0.50
- G52D (p.Gly52Asp), cosmic curated COSV10963, Ensembl rs2122195464
- G52R (p.Gly52Arg), Ensembl rs2122195459
- G52V (p.Gly52Val), gnomAD 19-41220705-G-T, REVEL 0.06, CADD 10.10
- G52G (p.Gly52Gly), rs374467939, gnomAD 19-41220706-C-A, CADD 2.98
- T53I (p.Thr53Ile), Ensembl rs2122195485, REVEL 0.09, CADD 15.60
- T53N (p.Thr53Asn), Ensembl rs2122195485
- T53P (p.Thr53Pro), cosmic curated COSV56573, Ensembl rs1599723309
Public AXL analysis runs
- AXL analysis run — AXL (1,797 variants) — completed 2026-08-21